Cargando…

Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier

Pathological hyperpermeability is a morbidity involved in various systemic diseases, including sepsis. The endothelial glycocalyx layer (GCX) plays a key role in controlling vascular permeability and could be a useful therapeutic target. The purpose of the present study was to analyze the functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kyoko, Tanaka, Junichi, Mishima, Kenji, Iijima, Takehiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177458/
https://www.ncbi.nlm.nih.gov/pubmed/34086745
http://dx.doi.org/10.1371/journal.pone.0252416
_version_ 1783703384981766144
author Abe, Kyoko
Tanaka, Junichi
Mishima, Kenji
Iijima, Takehiko
author_facet Abe, Kyoko
Tanaka, Junichi
Mishima, Kenji
Iijima, Takehiko
author_sort Abe, Kyoko
collection PubMed
description Pathological hyperpermeability is a morbidity involved in various systemic diseases, including sepsis. The endothelial glycocalyx layer (GCX) plays a key role in controlling vascular permeability and could be a useful therapeutic target. The purpose of the present study was to analyze the functional role of the GCX in vascular permeability and to elucidate its role in pathological conditions. First, male C57BL/6J wild-type mice were used as in vivo models to study the effects of sepsis and the pharmacological digestion of glycosaminoglycans (GAGs) on the GCX. Vascular permeability was evaluated using fluorescein isothiocyanate (FITC)-labeled dextran. Second, the changes in gene expression in vascular endothelial cells after GAGs digestion were compared between a control and a septic model using RNA sequencing. In the in vivo study, the glycocalyx was depleted in both the septic model and the group with pharmacological GAGs digestion. FITC-labeled dextran had leaked into the interstitium in the septic group, but not in the other groups. In the in vitro study, histamine decreased the transendothelial electrical resistance (TEER), indicating an increase in permeability. GAGs digestion alone did not change the TEER, and the effect of histamine on the TEER was not enhanced by GAGs digestion. The gene expression profiles after GAGs digestion differed from the control condition, indicating the initiation of signal transduction. In conclusion, we demonstrated that the structural barrier of the GCX does not solely determine the fluid permeability of the endothelial layer, since enzymatic depletion of the GCX did not increase the permeability. The gene expression findings suggest that the digestion of GAGs alone did not induce hyperpermeability either in vitro or in vivo, although sepsis did induce hyperpermeability. While GAGs degradation by itself does not appear to induce hyperpermeability, it may play an important role in initiating signal transductions.
format Online
Article
Text
id pubmed-8177458
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81774582021-06-07 Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier Abe, Kyoko Tanaka, Junichi Mishima, Kenji Iijima, Takehiko PLoS One Research Article Pathological hyperpermeability is a morbidity involved in various systemic diseases, including sepsis. The endothelial glycocalyx layer (GCX) plays a key role in controlling vascular permeability and could be a useful therapeutic target. The purpose of the present study was to analyze the functional role of the GCX in vascular permeability and to elucidate its role in pathological conditions. First, male C57BL/6J wild-type mice were used as in vivo models to study the effects of sepsis and the pharmacological digestion of glycosaminoglycans (GAGs) on the GCX. Vascular permeability was evaluated using fluorescein isothiocyanate (FITC)-labeled dextran. Second, the changes in gene expression in vascular endothelial cells after GAGs digestion were compared between a control and a septic model using RNA sequencing. In the in vivo study, the glycocalyx was depleted in both the septic model and the group with pharmacological GAGs digestion. FITC-labeled dextran had leaked into the interstitium in the septic group, but not in the other groups. In the in vitro study, histamine decreased the transendothelial electrical resistance (TEER), indicating an increase in permeability. GAGs digestion alone did not change the TEER, and the effect of histamine on the TEER was not enhanced by GAGs digestion. The gene expression profiles after GAGs digestion differed from the control condition, indicating the initiation of signal transduction. In conclusion, we demonstrated that the structural barrier of the GCX does not solely determine the fluid permeability of the endothelial layer, since enzymatic depletion of the GCX did not increase the permeability. The gene expression findings suggest that the digestion of GAGs alone did not induce hyperpermeability either in vitro or in vivo, although sepsis did induce hyperpermeability. While GAGs degradation by itself does not appear to induce hyperpermeability, it may play an important role in initiating signal transductions. Public Library of Science 2021-06-04 /pmc/articles/PMC8177458/ /pubmed/34086745 http://dx.doi.org/10.1371/journal.pone.0252416 Text en © 2021 Abe et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abe, Kyoko
Tanaka, Junichi
Mishima, Kenji
Iijima, Takehiko
Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title_full Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title_fullStr Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title_full_unstemmed Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title_short Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier
title_sort exploring the mechanism of hyperpermeability following glycocalyx degradation: beyond the glycocalyx as a structural barrier
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177458/
https://www.ncbi.nlm.nih.gov/pubmed/34086745
http://dx.doi.org/10.1371/journal.pone.0252416
work_keys_str_mv AT abekyoko exploringthemechanismofhyperpermeabilityfollowingglycocalyxdegradationbeyondtheglycocalyxasastructuralbarrier
AT tanakajunichi exploringthemechanismofhyperpermeabilityfollowingglycocalyxdegradationbeyondtheglycocalyxasastructuralbarrier
AT mishimakenji exploringthemechanismofhyperpermeabilityfollowingglycocalyxdegradationbeyondtheglycocalyxasastructuralbarrier
AT iijimatakehiko exploringthemechanismofhyperpermeabilityfollowingglycocalyxdegradationbeyondtheglycocalyxasastructuralbarrier